Trial intelligence / Profile preview

Pharmacokinetics of Voriconazole in Obese Subjects

NCT01030653Phase 4Completed

Start
Nov 2009
Primary completion
Apr 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, open-label trial of voriconazole in fungal infection (2 arms). Primary endpoints: Steady-State Maximum Plasma Concentration at Day 5, Steady-State Minimum Plasma Concentration at Day 5 and 1 more. Started Nov 2009; status: completed.

02

Drugs

voriconazole
03

Conditions

fungal infection

Beyond the preview

Go deeper on NCT01030653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01030653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call